Oppenheimer Reiterates Outperform Rating on Imperva (IMPV) Following Strong Q4
Tweet Send to a Friend
Oppenheimer analyst Shaul Eyal reiterates Outperform rating and $55 price target on Imperva Inc. (NYSE: IMPV), as the company reported ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


